Healthcare provider profile · identity verified

Trevor Wright Bush, MD

Hospitalist · KIMBALL, NE · NPI 1942380431

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	362	65
Atorvastatin Calcium	Atorvastatin Calcium	301	59
Amlodipine Besylate	Amlodipine Besylate	271	51
Lisinopril	Lisinopril	227	57
Gabapentin	Gabapentin	186	33
Losartan Potassium	Losartan Potassium	178	42
Omeprazole	Omeprazole	168	40
Hydrochlorothiazide	Hydrochlorothiazide	147	33
Simvastatin	Simvastatin	143	36
Pantoprazole Sodium	Pantoprazole Sodium	141	29
Metformin Hcl	Metformin Hcl	136	29
Metoprolol Tartrate	Metoprolol Tartrate	106	18
Metformin Hcl Er	Metformin Hcl	105	21
Montelukast Sodium	Montelukast Sodium	105	22
Trazodone Hcl	Trazodone Hcl	103	11
Metoprolol Succinate	Metoprolol Succinate	102	19
Sertraline Hcl	Sertraline Hcl	99	11
Celecoxib	Celecoxib	97	30
Tamsulosin Hcl	Tamsulosin Hcl	90	23
Potassium Chloride	Potassium Chloride	88	22
Tramadol Hcl	Tramadol Hcl	87	21
Carvedilol	Carvedilol	85	18
Rosuvastatin Calcium	Rosuvastatin Calcium	84	23
Allopurinol	Allopurinol	79	17
Venlafaxine Hcl Er	Venlafaxine Hcl	78	18
Clopidogrel	Clopidogrel Bisulfate	71	15
Furosemide	Furosemide	71	25
Prednisone	Prednisone	70	28
Jardiance	Empagliflozin	69	12
Donepezil Hcl	Donepezil Hcl	66	11
Meloxicam	Meloxicam	66	17
Duloxetine Hcl	Duloxetine Hcl	60	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	55	suppressed
Farxiga	Dapagliflozin Propanediol	52	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	suppressed
Spironolactone	Spironolactone	51	12
Buspirone Hcl	Buspirone Hcl	50	suppressed
Pravastatin Sodium	Pravastatin Sodium	48	suppressed
Eliquis	Apixaban	47	15
Methylprednisolone	Methylprednisolone	47	39
Fenofibrate	Fenofibrate	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	12
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	40	30
Ozempic	Semaglutide	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Lorazepam	Lorazepam	38	15
Memantine Hcl	Memantine Hcl	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Finasteride	Finasteride	36	suppressed
Mounjaro	Tirzepatide	35	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	34	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	12
Glipizide Er	Glipizide	32	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Tresiba Flextouch U-100	Insulin Degludec	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Klor-Con M20	Potassium Chloride	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Cephalexin	Cephalexin	28	25
Glimepiride	Glimepiride	28	suppressed
Glipizide	Glipizide	28	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Topiramate	Topiramate	26	suppressed
Atenolol	Atenolol	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Famotidine	Famotidine	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Estradiol	Estradiol	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Fluconazole	Fluconazole	15	14
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Linzess	Linaclotide	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Baclofen	Baclofen	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Fosinopril Sodium	Fosinopril Sodium	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error